Blood pressure control, hypertension, awareness, and treatment in adults with diabetes in the United States-Mexico border region

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 28, Issue 3, 2010, Pages 164-173

  Vijayaraghavan, Maya ^a   He, Guozhong ^a   Stoddard, Pamela ^b   Schillinger, Dean ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

Blood pressure; Border health; Diabetes mellitus; Disease management; Health services accessibility; Hypertension; Mexico; Type 2; United States

Indexed keywords

ADULT; BLOOD; BORDER REGION; DEMOGRAPHY; DISEASE CONTROL; DISEASE PREVALENCE; DISEASE TREATMENT; HYPERTENSION; IMMIGRATION; LOGISTICS; PRESSURE; PUBLIC HEALTH; REGRESSION ANALYSIS; RISK FACTOR;

FEDERAL DISTRICT [MEXICO]; MEXICO CITY; MEXICO [NORTH AMERICA]; UNITED STATES;

EID: 77958614215     PISSN: 10204989     EISSN: 16805348     Source Type: Journal    
DOI: 10.1590/S1020-49892010000900006     Document Type: Article

References (31)

1. Arauz-Pacheco C, Parrott MA, Raskin P. Treatment of hypertension in adults with diabetes. Diabetes Care. 2003;26(1 Suppl): S80-2.
2. Arauz-Pacheco C, Parrott MA, Raskin P. The treatment of hypertension in adult patients with diabetes. Diabetes Care. 2002;25(1): 134-47.
3. United Kingdom Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular microvascular complications in type 2 diabetes: UKPDS 38. Br Med J. 1998;317(7160): 703-13.
4. Heart Outcomes Prevention Evaluation Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet. 2000;355(9200): 253-9.
5. ACCORD Study Group, Cushman WC, Evans GW, Byington RP, Goff DC, Grimm RH Jr, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362(17): 1575-85.
6. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. J Am Med Assoc. 2003;290(2): 199-206.
7. Suh DC, Kim CM, Choi IS, Plauschinat CA, Barone JA. Trends in blood pressure control and treatment among type 2 diabetes with comorbid hypertension in the United States: 1988-2004. J Hypertens. 2009;27(9): 1908-16.
8. Cowie CC, Rust KF, Byrd-Holt DD, Eberhardt MS, Flegal KM, Engelgau MM, et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002. Diabetes Care. 2006;29(6): 1263-8.
9. Garcia-Garcia G, Aviles-Gomez R, Luquin- Arellano VH, Padilla-Ocho R, Lepe-Murillo L, Ibarra-Hernandez M, et al. Cardiovascular risk factors in the Mexican population. Ren Fail. 2006;28(8): 677-87.
10. Velásquez MO, Rosas Peralta M, Lara Esqueda A, Pastelín Hernández G, Attie F, Tapia Conyer R, et al. Arterial hypertension in Mexico: results of the National Health Survey 2000. Arch Cardiol Mex. 2002;72(1): 71-84.
11. Olaiz-Fernández G, Rojas R, Aguilar-Salinas CA, Rauda J, Villalpando S. Diabetes mellitus in Mexican adults: results from the 2000 National Health Survey. Salud Publica Mex. 2007;49(Suppl 3): S331-7.
12. Aguilar-Salinas CA, Velazquez MO, Gomez- Perez FJ, Gonzalez Chávez A, Esqueda AL, Molina Cuevas V, et al. Characteristics of patients with type 2 diabetes in Mexico: results from a large population-based nationwide survey. Diabetes Care. 2003;26(7): 2021-6.
13. Williams ME, Lacson E Jr, Teng M, Ofsthun N, Lazarus JM. Hemodialyzed type I and type II diabetic patients in the US: characteristics, glycemic control, and survival. Kidney Int. 2006;70(8): 1503-9.
14. Pugh JA, Stern MP, Haffner SM, Eifler CW, Zapata M. Excess incidence of treatment of end-stage renal disease in Mexican Americans. Am J Epidemiol. 1988;127(1): 135-44.
15. Peralta CA, Shlipak MG, Fan D, Ordoñez J, Lash JP, Chertow GM, et al. Risks for end- stage renal disease, cardiovascular events, and death in Hispanic versus non-Hispanic white adults with chronic kidney disease. J Am Soc Nephrol. 2006;17(10): 2892-9.
16. Hall YN, Choi AI, Chertow GM, Bindman AB. Chronic kidney disease in the urban poor. Clin J Am Soc Nephrol. 2010;5(5): 828-35.
17. Pan American Health Organization. United States-Mexico border area. In: Health in the Americas, 2007. Vol. II. Countries. Washington, D.C.: PAHO; 2007. (Scientific Publication 622).
18. Rao SP. The health and well-being of individuals, families, and communities that make up the US-Mexico border region. Foreword. Fam Community Health. 2009;32(1): 2-3.
19. United States-Mexico Border Health Commission. Topic brief: health care reform: border challenges and opportunities. El Paso, TX: USMBHC; 2009. Available from: http://www.borderhealth.org/files/res-1356.pdf. Accessed 12 March 2010.
20. DeNavas-Walt C, Proctor BD, Smith JC, U.S. Census Bureau. Income, poverty and health insurance coverage in the United States: 2007. Current population reports, P-60-235. Washington, D.C.: U.S. Government Printing Office; 2008.
21. Pan American Health Organization; U.S. Centers for Disease Control and Prevention. The U.S.-Mexico Border Diabetes Prevention and Control Project: first report of results. Washington, D.C.: PAHO; 2005.
22. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Bethesda, MD: National Institute of Health, High Blood Pressure Education Program, National Heart, Lung, and Blood Institute; 2004. (NIH Publication 04-5230).
23. Ahmad O, Boschi-Pinto C, Lopez AD, Murrary CJL, Lozano R, Inoue M. Age standardization of rates: a new WHO standard. GPE. Geneva: World Health Organization; 2001. (Discussion Paper no. 31. EIP/GPE/EBD).
24. Vijan S, Hayward RA. Treatment of hypertension in type 2 diabetes mellitus: blood pressure goals, choice of agents, and setting priorities in diabetes care. Ann Intern Med. 2003; 138(7): 593-602.
25. Adler AI, Stratton IM, Neil HA, Yudkin JS, Matthews DR, Cull CA, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. Br Med J. 2000;321(7258): 412-9.
26. Zhang P, Engelgau MM, Norris SL, Gregg EW, Narayan KM. Application of economic analysis to diabetes and diabetes care. Ann Intern Med. 2004;140(11): 972-7.
27. Benabe JE, Rios EV. Kidney disease in the Hispanic population: facing the growing challenge. J Natl Med Assoc. 2004;96(6): 789-98.
28. Morales LS, Lara M, Kington RS, Valdez RO, Escarce JJ. Socioeconomic, cultural, and behavioral factors affecting Hispanic health outcomes. J Health Care Poor Underserved. 2002; 13(4): 477-503.
29. Lara M, Gamboa C, Kahramanian MI, Morales LS, Bautista DE. Acculturation and Latino health in the United States: a review of the literature and its sociopolitical context. Annu Rev Public Health. 2005;26: 367-97.
30. Dey AN, Lucas JW. Physical and mental health characteristics of U.S.- and foreign-born adults: United States, 1998-2003. Adv Data. 2006(369): 1-19.
31. Bibbins-Domingo K, Chertow GM, Coxson PG, Moran A, Lightwood JM, Pletcher MJ, et al. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med. 2010;362(7): 590-9.